# Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia

> **NCT01137747** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 18 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** Carfilzomib

## Key facts

- **NCT ID:** NCT01137747
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-08
- **Final completion:** 2015-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01137747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01137747, "Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01137747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*